适合挽救性放疗的前列腺癌患者中镓-68 PSMA-11 PET扫描显示的复发位置
该回顾性研究纳入125例根治性前列腺切除术后生化复发且PSA≤2.0 ng/mL的患者,行镓-68 PSMA-11 PET成像,评估复发灶是否在标准放疗靶区内。结果显示66例(53%)存在PSMA阳性病灶,其中38例(30%)的盆腔淋巴结病变不被标准IMRT盆腔淋巴结照射野覆盖。
要点
- PSA≤2.0 ng/mL的生化复发患者中,53%(66/125)经68Ga-PSMA-11 PET检出PSMA阳性病灶。
- 38例(30%)患者的PSMA阳性淋巴结病变位于标准IMRT盆腔淋巴结照射野之外。
- 成像时PSA水平与标准淋巴结野外存在PSMA阳性病灶有统计学关联(P<.01)。
核心结论
- 68Ga-PSMA-11 PET在多数根治性前列腺切除术后PSA≤2.0 ng/mL的患者中可检出病灶,近三分之一患者的PSMA阳性病灶会被标准放疗野遗漏,该成像方式可能显著影响术后挽救性放疗的设计和使用。
研究设计与样本
- 回顾性综述,纳入125例根治性前列腺切除术后生化复发且PSA≤2.0 ng/mL并接受PSMA-PET成像的患者。
主要发现
- 成像时中位PSA为0.40 ng/mL(四分位距0.28-0.63)。
- 66例(53%)存在PSMA阳性病灶,其中25例(38%)有盆腔外PSMA阳性病灶,33例(50%)病灶局限于盆腔淋巴结和前列腺床,8例(12%)仅前列腺床有PSMA阳性复发。
- 标准IMRT盆腔淋巴结照射野不能覆盖38例(30%)患者的PSMA阳性淋巴结病变。
- 成像时PSA水平与标准淋巴结野外存在PSMA阳性病灶有统计学关联(P<.01)。
临床怎么用
- 原文结论指出该成像方式可能显著影响术后挽救性放疗的设计和使用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To identify locations of recurrence after radical prostatectomy (RP) with prostate-specific antigen (PSA) <2 by Gallium-68 prostate-specific membrane antigen (PSMA)-11 Positron Emission Tomography (PET) imaging, and to determine whether standard nodal radiation fields would cover the location of prostate cancer recurrence. MATERIALS AND METHODS: We performed a retrospective review of patients with PSMA-PET imaging for biochemical recurrence following RP with PSA ≤2.0 ng/mL and assessed if the recurrent disease was within standard radiation target volumes. We compared patient and clinical variables between men with recurrences covered by standard salvage radiation fields and those with recurrences outside of standard fields. RESULTS: We identified 125 patients for study inclusion. The median PSA at imaging was 0.40 ng/mL (interquartile range 0.28-0.63). PSMA-avid disease was found in 66 patients (53%). Of these, 25 patients (38%) had PSMA-avid lesions found outside of the pelvis, 33 (50%) had lesions confined to the pelvic lymph nodes and prostate bed, and 8 (12%) men had PSMA-avid recurrence only in the prostate bed. Salvage radiation including standard Intensity Modulated Radiation Therapy (IMRT) pelvic nodal volumes would not cover PSMA-avid nodal disease in 38 men (30%). PSA at the time of imaging was statistically associated with having PSMA-avid disease outside of standard nodal fields (P <.01). CONCLUSION: The 68Ga-PSMA-11 PET detects disease in a majority of patients with PSA ≤2.0 following RP. Nearly one-third of men had PSMA-avid disease that would be missed by standard radiation fields. This imaging modality may dramatically impact the design and use of post-RP salvage radiotherapy.
引用
- Boreta L, Gadzinski AJ, Wu SY, et al. Location of Recurrence by Gallium-68 PSMA-11 PET Scan in Prostate Cancer Patients Eligible for Salvage Radiotherapy. Urology. 2019. PMID: 30928607. doi:10.1016/j.urology.2018.12.055
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。